July 8, 2026 · Form 4 insider transaction
Hagler Mark Arnold bought 949,050 shares of NovaBridge Biosciences at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Number of underlying securities and exercise price expressed in terms of American Depositary Shares ("ADS").; The option vests and becomes exercisable in four equal annual installments beginning on the first anniversary of April 17, 2026.; The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer.